1. Home
  2. LRMR vs OPBK Comparison

LRMR vs OPBK Comparison

Compare LRMR & OPBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • OPBK
  • Stock Information
  • Founded
  • LRMR N/A
  • OPBK 2005
  • Country
  • LRMR United States
  • OPBK United States
  • Employees
  • LRMR N/A
  • OPBK N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • OPBK Major Banks
  • Sector
  • LRMR Health Care
  • OPBK Finance
  • Exchange
  • LRMR Nasdaq
  • OPBK Nasdaq
  • Market Cap
  • LRMR 171.6M
  • OPBK 188.6M
  • IPO Year
  • LRMR N/A
  • OPBK 2018
  • Fundamental
  • Price
  • LRMR $2.67
  • OPBK $11.69
  • Analyst Decision
  • LRMR Strong Buy
  • OPBK Hold
  • Analyst Count
  • LRMR 7
  • OPBK 1
  • Target Price
  • LRMR $18.86
  • OPBK $18.00
  • AVG Volume (30 Days)
  • LRMR 1.1M
  • OPBK 62.5K
  • Earning Date
  • LRMR 08-06-2025
  • OPBK 07-24-2025
  • Dividend Yield
  • LRMR N/A
  • OPBK 4.10%
  • EPS Growth
  • LRMR N/A
  • OPBK 0.92
  • EPS
  • LRMR N/A
  • OPBK 1.42
  • Revenue
  • LRMR N/A
  • OPBK $81,356,000.00
  • Revenue This Year
  • LRMR N/A
  • OPBK $19.87
  • Revenue Next Year
  • LRMR N/A
  • OPBK $10.60
  • P/E Ratio
  • LRMR N/A
  • OPBK $8.27
  • Revenue Growth
  • LRMR N/A
  • OPBK 4.15
  • 52 Week Low
  • LRMR $1.61
  • OPBK $9.28
  • 52 Week High
  • LRMR $11.20
  • OPBK $18.57
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 56.20
  • OPBK 41.54
  • Support Level
  • LRMR $2.60
  • OPBK $11.57
  • Resistance Level
  • LRMR $3.02
  • OPBK $11.94
  • Average True Range (ATR)
  • LRMR 0.25
  • OPBK 0.33
  • MACD
  • LRMR 0.01
  • OPBK -0.07
  • Stochastic Oscillator
  • LRMR 51.35
  • OPBK 20.34

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About OPBK OP Bancorp

OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.

Share on Social Networks: